Acquisition of shares in Bushu Pharmaceuticals by KKR (represented KKR) Home Practices Acquisition of shares in Bushu Pharmaceuticals by KKR (represented KKR) Period December, 2022 Practices M&A People Shuhei Uchida Shuhei Uchida Partner Tokyo +81-3-5220-1859 shuhei.uchida@morihamada.com M&A Corporate Law Masaaki Hirota Masaaki Hirota Partner Tokyo +81-3-6266-8985 masaaki.hirota@morihamada.com M&A Structured Finance / Banking Kei Shirakawa Kei Shirakawa Partner Tokyo +81-3-6266-8916 kei.shirakawa@morihamada.com Structured Finance / Banking Energy / Infrastructure Yasutaka Tokuda Yasutaka Tokuda Partner Tokyo +81-3-6266-8934 yasutaka.tokuda@morihamada.com M&A Crisis Management / Compliance Life Science / Healthcare Consumer Law Public Policy Shuhei Takaishi Shuhei Takaishi Partner Tokyo +81-3-6213-8112 shuhei.takaishi@morihamada.com Structured Finance / Banking Energy / Infrastructure Real Estate / REITs Financial Regulation Takahiro Kobayashi Takahiro Kobayashi Senior Associate Tokyo +81-3-5220-1856 M&A Corporate Law Related Cases May, 2025 Case Highlights NTT: Acquisition of NTT Data for JPY 2.37 trillion Minoru Sawaguchi Akira Matsushita Shimpei Ochi April, 2025 Privatization of AEON MALL Katsumasa Suzuki Takafumi Goto April, 2025 Mori Hamada advised gumi in its formation of blockchain node operating JV in Japan with TIS Masafumi Masuda Takaaki Okano Kosuke Esumi April, 2025 Represented TENMA CORPORATION in connection with MBO by FHL Holdings Inc. through a tender offer Yohei Koyama Kohei Morita Yurika Inoue Yasuhisa Watanabe Taishu Yamashita Taishi Koyama March, 2025 Case Highlights T&D Holdings: Acquisition of Viridium Group from Cinven Limited Kenichi Sekiguchi Kazuo Yoshida Makoto Sakai Henry Lau Hiromu Suemasa Jaejoong Kim Hiroki Inomata March, 2025 Case Highlights Investment in class shares of Toho Zinc by funds serviced by Advantage Partners Masakazu Kumagai Tetsuya Tamura Tomohiro Oka Go back to Cases